Wagner, Tyler D. https://orcid.org/0000-0001-7248-4890
Riposo, Jacqlyn W.
Gould, Kendra M.
Campbell, Jonathan D.
Kenney, James T.
Csenge, Claire M.
Schmidt, Theresa
Funding for this research was provided by:
National Pharmaceutical Council
Article History
Received: 13 August 2025
Accepted: 23 October 2025
First Online: 27 November 2025
Declarations
:
: Tyler D. Wagner, Jacqlyn W. Riposo, Kendra M. Gould, Jonathan D. Campbell, James T. Kenney, Claire M. Csenge, and Theresa Schmidt have no conflicts of interest that are directly relevant to content of this study.
: The interviews completed as part of this study received institutional review board exemption determination by Advarra Institutional Review Board (Pro00084698).
: Interview participants provided verbal consent to participate.
: Not applicable.
: Qualitative data including recordings and transcripts from interviews are retained on a secure online platform that can only be accessed by the study leads. Per the institutional review board requirement, all recordings and transcriptions will be destroyed within 12 months of study completion. A thematic summary of the interviews is available upon request.
: Not applicable.
: TDW: funding acquisition, conceptualization, methodology, writing (original draft preparation), review and editing. JWR: conceptualization, methodology, investigation, formal analysis, writing (original draft preparation), review and editing. KMG: project administration, conceptualization, methodology, investigation, formal analysis, writing (original draft preparation), review and editing. JDC: funding acquisition, conceptualization, methodology, supervision, review and editing. JTK: investigation, review and editing. CMC: investigation, writing (original draft preparation). TS: conceptualization, methodology, investigation, formal analysis, writing (original draft preparation), review and editing. All authors read and approved the final manuscript.